Cargando…
Fibrinogen-Like Protein 1 Is a Novel Biomarker for Predicting Disease Activity and Prognosis of Rheumatoid Arthritis
Rheumatoid arthritis (RA), afflicting over 1% of the population, is an inflammatory joint disease leading to cartilage damage and ultimately impaired joint function. Disease-modifying anti-rheumatic drugs are considered as the first-line treatment to inhibit the progression of RA, and the treatment...
Autores principales: | Liu, Shijia, Guo, Yunke, Lu, Lu, Lu, Jiawei, Ke, Mengying, Xu, Tingting, Lu, Yan, Chen, Wenjun, Wang, Jue, Kong, Deshun, Shen, Qiuxiang, Zhu, Youjuan, Tan, WenFeng, Ji, Wei, Zhou, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574527/ https://www.ncbi.nlm.nih.gov/pubmed/33123164 http://dx.doi.org/10.3389/fimmu.2020.579228 |
Ejemplares similares
-
Serum metabolomic and lipidomic profiling identifies diagnostic biomarkers for seropositive and seronegative rheumatoid arthritis patients
por: Luan, Hemi, et al.
Publicado: (2021) -
Lipid metabolism and rheumatoid arthritis
por: Lei, Qian, et al.
Publicado: (2023) -
Fibrinogen-Like Protein 1 Serves as an Anti-Inflammatory Agent for Collagen-Induced Arthritis Therapy in Mice
por: Lin, Wen-Wei, et al.
Publicado: (2021) -
Fibrinogen-specific T cells in rheumatoid arthritis
por: Vossenaar, E, et al.
Publicado: (2003) -
Identifying Immune Cell Infiltration and Effective Diagnostic Biomarkers in Rheumatoid Arthritis by Bioinformatics Analysis
por: Zhou, Sheng, et al.
Publicado: (2021)